Bausch Health Companies Inc
Bausch Health Companies Inc/ CA0717341071 /
BHC
|
2024-11-12 10:00:02 PM
|
Chg.
-0.22
|
Volume |
Bid10:01:02 PM |
Ask10:01:02 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
9.13USD
|
-2.35%
|
1.63 mill.
Turnover: 13.14 mill. |
9.13Bid Size: 200 |
9.32Ask Size: 300 |
3.35 bill.USD |
- |
- |
Business description
Bausch Health Companies Inc. is a global company whose mission is to improve people's lives with health care products. Bausch develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
Management board & Supervisory board
| CEO |
| Thomas J. Appio |
| Management board |
| Jean-Jacques Charhon, Seana Carson, Mirza Dautbegovic, Kathleen Fitzpatrick, Cees Heiman, Jiny Kim, Donald Pearl, Fernando Zarate, Aimee Lenar |
| Supervisory board |
| John A. Paulson, Thomas J. Appio, Brett M. Icahn, Sarah B. Kavanagh, Steven D. Miller, Dr. Richard Mulligan, Robert N. Power, Amy B. Wechsler, M.D., Frank D. Lee, Christian A. Garcia |
Company data
| Name: |
Bausch Health Companies Inc. |
| Address: |
2150 St. Elzéar Blvd. West,Laval, Quebec H7L 4A8, Canada |
| Phone: |
+1(800) 361-1448 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.bauschhealth.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
Arthur Shannon |
| IR phone: |
+1-877-281-6642 |
| IR Fax: |
- |
| IR e-mail: |
ir@bauschhealth.com
|
